Main Article Content
Major advances have been made in the delivery of care and outcomes for those with asthma and COPD
over the last few decades. However, much of that progress represents the success of the pharmaceutical
industry in producing and promoting efficacious medications. Further improvements in outcomes for those
with common lung diseases is only likely to occur if doctors embrace the wider non-prescription elements
of care with such elements including everything from enhanced communication, shared decision making,
self-management support, pulmonary rehabilitation and easier and more convenient follow up.
This review concerns one vital element of that wider package of care, namely self-management support.
Work published in JPMI is licensed under a
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.